News

Tisch MSRCNY's Phase II Results
06/16/2023

We are very excited to share that the highly-anticipated Phase II results of our FDA-approved stem cell treatment study have been released. 

... more

Consortium of Multiple Sclerosis Centers 2023 Annual Meeting

06/05/2023

Two of our wonderful nurses attended the Annual Meeting of the CMSC in Colorado. The Consortium of Multiple Sclerosis Centers Annual Meeting is the largest North American meeting for healthcare professionals and researchers engaged in MS care.

Summer Fridays
06/02/2023

In appreciation of our staff's hard work throughout the year, the IMSMP will be closing at 2:15 PM on Fridays from now until Labor Day weekend.

Memorial Day
05/26/2023

In observance of Memorial Day, the IMSMP will be closing on 5/26/23 at 1:00PM and will reopen on 5/30/23 at 9:00AM

2023 Symposium Recap
04/28/2023
... more

MS Awareness Month
03/06/2023

Tisch MSRCNY Symposium Topics Announced!

02/01/2023

Tisch MSRCNY Hosts 23rd Annual MS Patient Education Symposium
MS Continuum: Where we were, Where we are & Where we are going
Sunday, March 19th, 2023 9:30 am to 1:00 pm 
New York Hilton Midtown: 1335 Avenue of the... more

AmazonSmile
01/20/2023

By choosing Tisch MSRCNY as your charitable recipient on Amazon Smile, Amazon will donate to our laboratory at no additional cost to you.

... more

Martin Luther King Jr
01/13/2023

The IMSMP will be closed on Monday, January 16, 2023, in observance of Martin Luther King Jr. Day.

 

Ublituximab (BriumviTM) Approval
01/12/2023

The FDA recently approved ublituximab (BriumviTM) for the treatment of relapsing forms of Multiple Sclerosis. Ublituximab is a member of the anti-B cell (anti-CD20 monoclonal antibody) family of drugs, which includes rituximab (RituxanTM), ocrelizumab (OcrevusTM), and ofatumumab (KesimptaTM). The primary difference between these drugs is how they are administered and the length of time required to safely administer the medication. Ublituximab, like... more

Pages

IMSMP

Because you deserve only the best in MS healthcare. Experience the difference.

521 West 57th Street

4th Floor

New York, NY 10019

p: 212.265.8070

f: 212.265.8194

Privacy Policy

        

Newsletter Sign Up

Join our mailing list today!  Receive the latest information and updates happening in MS research, treatment and care including, Healing MS, the IMSMP newsletter.

* We don’t share your information with anyone.